September 29, 2020
The Sosei Group said on September 28 that the second novel drug candidate has entered clinical trials under its multi-target drug discovery partnership pact with Pfizer on G protein-coupled receptor (GPCR)-targeted oral small molecule compounds, triggering a milestone payment of...read more